RODILON PRO RODENTICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rodilon pro rodenticide

liphatech s.a.s. - difethialone - bait - difethialone ungrouped active 0.025 g/kg - vertebrate poison

DEFENDER SNAIL & SLUG PELLETS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

defender snail & slug pellets

evergreen garden care australia pty ltd - metaldehyde - pellet (eg snail bait) - metaldehyde aldehyde active 15.0 g/kg - molluscicide - garden - common slug | snail | bradybaena similaris | deroceras caruanae | helix aspersa | sigmurethra | theba pisana

Actifed CC Dry Cough New Zealand - English - Medsafe (Medicines Safety Authority)

actifed cc dry cough

pfizer consumer healthcare div. of pfizer new zealand ltd - pholcodine 1 mg/ml - oral solution - 1 mg/ml - active: pholcodine 1 mg/ml excipient: citric acid forest fruits flavour 502874a glycerol propylene glycol purified water saccharin sodium sodium cyclamate vanilla flavour 105486 xanthan gum

Alophen New Zealand - English - Medsafe (Medicines Safety Authority)

alophen

pfizer consumer healthcare div. of pfizer new zealand ltd - aloin 16.2mg; atropa belladonna 5.4mg (prepared herb); ipecacuanha 4.32mg; phenolphthalein 32.4mg - tablet - 16.2/5.4/4.32/32.4mg - active: aloin 16.2mg atropa belladonna 5.4mg (prepared herb) ipecacuanha 4.32mg phenolphthalein 32.4mg

Alpha-Tamoxifen New Zealand - English - Medsafe (Medicines Safety Authority)

alpha-tamoxifen

alpha pharmaceuticals limited - tamoxifen citrate 15.2mg equivalent to tamoxifen 10 mg;   - tablet - 10 mg - active: tamoxifen citrate 15.2mg equivalent to tamoxifen 10 mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone

Alpha-Tamoxifen New Zealand - English - Medsafe (Medicines Safety Authority)

alpha-tamoxifen

alpha pharmaceuticals limited - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg;   - tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone

Amcal Cough Suppressant Double Strength New Zealand - English - Medsafe (Medicines Safety Authority)

amcal cough suppressant double strength

pharmacy retailing (nz) limited - pholcodine 0.2%{relative} - linctus - 2 mg/ml - active: pholcodine 0.2%{relative} excipient: amaranth citric acid ethanol nipastat sucrose sunset yellow fcf

Amcal Cough Suppressant Regular Strength New Zealand - English - Medsafe (Medicines Safety Authority)

amcal cough suppressant regular strength

pharmacy retailing (nz) limited - pholcodine 0.1%{relative} - linctus - 1 mg/ml - active: pholcodine 0.1%{relative} excipient: amaranth citric acid ethanol nipastat purified water sucrose sunset yellow fcf

Movapo New Zealand - English - Medsafe (Medicines Safety Authority)

movapo

carsl consulting - apomorphine hydrochloride hemihydrate 5 mg/ml - solution for infusion - 5 mg/ml - active: apomorphine hydrochloride hemihydrate 5 mg/ml excipient: hydrochloric acid nitrogen sodium metabisulfite water for injection - apomine pfs is indicated for the treatment of motor fluctuations ('on-off' phenomena) in patients with parkinson's disease which are not sufficiently controlled by oral anti-parkinson's medication.

Arrow - Morphine LA New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - morphine la

teva pharma (new zealand) limited - morphine sulfate pentahydrate 100mg - modified release tablet - 100 mg - active: morphine sulfate pentahydrate 100mg excipient: hyetellose hypromellose magnesium stearate opadry grey oy-8238 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.